140 related articles for article (PubMed ID: 9793769)
21. Oxidative DNA damage in pterygium.
Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Lin CL; Chang KC
Mol Vis; 2005 Jan; 11():71-5. PubMed ID: 15692461
[TBL] [Abstract][Full Text] [Related]
22. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium.
Tan DT; Lim AS; Goh HS; Smith DR
Am J Ophthalmol; 1997 Mar; 123(3):404-5. PubMed ID: 9063255
[TBL] [Abstract][Full Text] [Related]
23. Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva.
Liang K; Jiang Z; Ding BQ; Cheng P; Huang DK; Tao LM
Mol Vis; 2011; 17():1687-93. PubMed ID: 21738398
[TBL] [Abstract][Full Text] [Related]
24. The expression and significance of p53 protein and Ki-67 protein in pterygium.
Ljubojević V; Gajanin R; Amidzić L; Vujković Z
Vojnosanit Pregl; 2016 Jan; 73(1):16-20. PubMed ID: 26964379
[TBL] [Abstract][Full Text] [Related]
25. The role of cyclin D1, BCL-2, p53 and Ki-67 in epithelial cells in the etiopathogenesis of pterygium.
Süren E; Nergiz D; Bilgin B; Çoban DT; Akgündüz Z; Sadullahoğlu C; Süren D
Indian J Pathol Microbiol; 2021; 64(2):238-242. PubMed ID: 33851614
[TBL] [Abstract][Full Text] [Related]
26. TP53 gene expression, codon 72 polymorphism and human papillomavirus DNA associated with pterygium.
Rodrigues FW; Arruda JT; Silva RE; Moura KK
Genet Mol Res; 2008; 7(4):1251-8. PubMed ID: 19065760
[TBL] [Abstract][Full Text] [Related]
27. Cyclooxygenase 2 expression in pterygium.
Chiang CC; Cheng YW; Lin CL; Lee H; Tsai FJ; Tseng SH; Tsai YY
Mol Vis; 2007 Apr; 13():635-8. PubMed ID: 17515883
[TBL] [Abstract][Full Text] [Related]
28. A novel role for CRIM1 in the corneal response to UV and pterygium development.
Maurizi E; Schiroli D; Atkinson SD; Mairs L; Courtney DG; O'Hagan B; McGilligan VE; Pagnamenta AT; Taylor JC; Vasquez JJD; Illanes-Velarde DE; Goldsmith D; Gouws P; Moore JE; Nesbit MA; Moore CBT
Exp Eye Res; 2019 Feb; 179():75-92. PubMed ID: 30365943
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of c-Myc in pterygium and cultured pterygial cells.
Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
[TBL] [Abstract][Full Text] [Related]
30. HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation.
Han SJ; Min HJ; Yoon SC; Ko EA; Park SJ; Yoon JH; Shin JS; Seo KY
Cell Death Dis; 2015 Aug; 6(8):e1863. PubMed ID: 26313914
[TBL] [Abstract][Full Text] [Related]
31. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors.
Dushku N; Hatcher SL; Albert DM; Reid TW
Arch Ophthalmol; 1999 Dec; 117(12):1593-9. PubMed ID: 10604662
[TBL] [Abstract][Full Text] [Related]
32. Relative gene expression analysis of human pterygium tissues and UV radiation-evoked gene expression patterns in corneal and conjunctival cells.
Shibata N; Ishida H; Kiyokawa E; Singh DP; Sasaki H; Kubo E
Exp Eye Res; 2020 Oct; 199():108194. PubMed ID: 32822701
[TBL] [Abstract][Full Text] [Related]
33. A novel role for Livin in the response to ultraviolet B radiation and pterygium development.
Wu SQ; Xu QB; Sheng WY; Su LY; Zhu LW
Int J Mol Med; 2020 Apr; 45(4):1103-1111. PubMed ID: 32124942
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for pterygium: Latest research progress on major pathogenesis.
Ding P; Wang R; He Y
Exp Eye Res; 2024 Jun; 243():109900. PubMed ID: 38636803
[TBL] [Abstract][Full Text] [Related]
35. Study of the expression of CD30 in pterygia compared to healthy conjunctivas.
Garfias Y; Bautista-De Lucio VM; García C; Nava A; Villalvazo L; Jiménez-Martínez MC
Mol Vis; 2009 Oct; 15():2068-73. PubMed ID: 19862340
[TBL] [Abstract][Full Text] [Related]
36. Deregulation of p53/survivin apoptotic markers correlated to PTEN expression in pterygium neoplastic cells.
Konstantopoulou K; Tsiambas E; Baliou E; Lazaris AC; Kavantzas N; Karameris A; Fotiades PP; Asproudis I; Ragos V; Vilaras G; Patsouris E; Konstantopoulou K; Tsiambas E; Baliou E; Lazaris AC; Kavantzas N; Karameris A; Fotiades PP; Asproudis I; Ragos V; Vilaras G; Patsouris E
J BUON; 2018; 23(3):826-831. PubMed ID: 30003758
[TBL] [Abstract][Full Text] [Related]
37. Pathogenesis of pterygium.
Hill JC; Maske R
Eye (Lond); 1989; 3 ( Pt 2)():218-26. PubMed ID: 2695353
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of human pterygium.
Perra MT; Maxia C; Zucca I; Piras F; Sirigu P
Histol Histopathol; 2002 Jan; 17(1):139-49. PubMed ID: 11813864
[TBL] [Abstract][Full Text] [Related]
39. Proliferative activity and p53 expression in primary and recurrent pterygia.
Chowers I; Pe'er J; Zamir E; Livni N; Ilsar M; Frucht-Pery J
Ophthalmology; 2001 May; 108(5):985-8. PubMed ID: 11320032
[TBL] [Abstract][Full Text] [Related]
40. Increased Expression of Aquaporin-1 and Aquaporin-3 in Pterygium.
Ortak H; Cayli S; Ocakli S; Demir S
Cornea; 2013 Oct; 32(10):1375-9. PubMed ID: 23974882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
